Walgreens Boots Alliance is likely to litigate should the Federal Trade Commission sue to block its proposed merger of Rite Aid, Cowen analyst Charles Rhyee opined according to a StreetInsider.com report published Wednesday. Rite Aid's value "remains significant" Rhyee noted. "This leads us to believe if the FTC were to block, WBA would litigate to win Rite Aid," he said. A deadlocked FTC is also a possibility, according to Rhyee. "The FTC Chairman, Maureen Ohlhausen, who is likely more favorable to the transaction, could use the 1-1 vote as leverage to build consensus and arrive at a consent decree." (StreetInsider.com)
Coming from a diverse neighborhood gave her ‘street smarts,’ but Rite Aid’s head of pharmacy tells Drug Store News her most important leadership lessons came from two pillars of the Philadelphia community — her mom and dad.
Sales of artificial eyelashes packaged with adhesives rose 31% to $157 million, according to IRI data for multi-outlet retailers for the 52-week period ended March 19. Eyelash adhesives kicked in another $30 million and showed growth of 24%.
According to a report in TheStreet published Monday, CNBC "Mad Money" host Jim Cramer advised Walgreens shareholders to hold on to what they have, because no matter how the Rite Aid deal pans out, Walgreens will win. "If the deal's derailed by the FTC, I think we're going to get a truly monster buyback," Cramer said during an exclusive monthly conference call for members of his Action Alert Plus investment club. "If the deal is accepted, analysts can raise their numbers substantially. Those are good outcomes." (TheStreet)
For its 2017 fiscal fourth quarter ended March 4, Rite Aid reported revenues of $8.5 billion and a net loss of $21.1 million. Its adjusted net loss came in at $3.2 million, which bested Wall Street estimates.
Albertsons, Rite Aid, CVS, Walgreens and Walmart all saw significant rises in year-over-year satisfaction, with all advancing at least 3% year over year, according to the American Customer Satisfaction Index.
Wall Street investors have faith that the Federal Trade Commission will approve Walgreens Boots Alliance’s proposed acquisition of Rite Aid — and that’s having a positive influence on Walgreens’ stock, according to Crain’s Chicago Business. WBA’s shares have been up 6% this year and up 19% over March 2016, which Morningstar analyst Vishnu Lekraj says is due to “investor optimism that they’re going to be able to close the Rite Aid transaction.” (Crain’s Chicago Business)
Walgreens reportedly is weighing whether or not to declare that its FTC application has "certified compliance," which would force the Federal Trade Commission to vote on its proposed acquisition of Rite Aid quickly.